Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03487666 |
|---|---|
| Brief Title: | OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease |
| First Submitted : | March 20, 2018 |
| First Submitted that Met QC Criteria : | April 2, 2018 |
| First Posted : | April 4, 2018 |
| Last Update Submitted that Met QC Criteria : | March 14, 2022 |
| Last Update Posted : | March 15, 2022 |